Your browser doesn't support javascript.
loading
Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients.
Kim, Tong-Yoon; Kwag, Daehun; Lee, Jong-Hyuk; Lee, Joonyeop; Min, Gi-June; Park, Sung-Soo; Park, Silvia; Jeon, Young-Woo; Yoon, Jae-Ho; Shin, Seung-Hawn; Yahng, Seung-Ah; Cho, Byung-Sik; Eom, Ki-Seong; Kim, Yoo-Jin; Lee, Seok; Kim, Hee-Je; Min, Chang-Ki; Cho, Seok-Goo; Lee, Jong-Wook; Lee, Jong-Mi; Kim, Myungshin; Lee, Sung-Eun.
Afiliação
  • Kim TY; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Kwag D; Department of Hematology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Lee JH; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Lee J; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Min GJ; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Park SS; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Park S; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Jeon YW; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Yoon JH; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Shin SH; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Yahng SA; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Cho BS; Department of Hematology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Eom KS; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Kim YJ; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Lee S; Department of Hematology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Kim HJ; Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Min CK; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Cho SG; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Lee JW; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Lee JM; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Kim M; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Lee SE; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Cancers (Basel) ; 14(18)2022 Sep 16.
Article em En | MEDLINE | ID: mdl-36139644
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article